Make data-driven decisions while your study is ongoing. Real-time integration of disparate study data and analytics on Xbiom™ Insights.
Study Reports published after completion offer little opportunity for on-study decisions. Xbiom™ enables you to identify toxicity signals early, adapt protocols, and consider new trial designs by monitoring interim data loaded as often as twice-daily.
Our solution aggregates and integrates disparate LIMS and Assay data from multiple sources, making it available to sponsor toxicologists in near-real-time.
The Study Monitor is empowered to decide with agile aggregation of data from multiple sources.
Delivered on a private, encrypted, cloud-based environment for secure, authorized access.
A virtual team of data scientists and statisticians collecting and loading cytokines, bioanalytic, OMICs, and other data.
Integrates disparate LIMS and Assay data. Accommodates all in-vivo studies including Transgenic, Xenograft, or Animal Rule models.
Analyze data in any way you wish, with any grouping or cohorts, on a powerful and intuitive data platform.
Final datasets can be cross-checked against the interim set, assuring data consistency and minimal data gaps.
SEND datasets with nSDRG and Define.xml can be generated from this integrated data at 50% of the indicative SEND cost.
For small BioTechs, we also offer board certified toxicologists for consults.
Periodic analysis and visualization while monitoring your study means fewer surprises when the final dataset is prepared.